{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:25:05Z","timestamp":1761128705087},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.jbspin.2007.10.011","type":"journal-article","created":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T05:54:01Z","timestamp":1217570041000},"page":"540-543","source":"Crossref","is-referenced-by-count":34,"title":["Herpes zoster in patients taking TNF\u03b1 antagonists for chronic inflammatory joint disease"],"prefix":"10.1016","volume":"75","author":[{"given":"Daniel","family":"Wendling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rald","family":"Streit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Toussirot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Prati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2007.10.011_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jbspin.2006.11.020","article-title":"TNF alpha antagonist therapy in patients with joint disease and chronic viral infection","volume":"74","author":"Wendling","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2007.10.011_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/pmj.2003.014373","article-title":"Severe herpes zoster after infliximab infusion","volume":"80","author":"Kinder","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jbspin.2007.10.011_bib3","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","article-title":"Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2007.10.011_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F","article-title":"Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"Suppl. II","key":"10.1016\/j.jbspin.2007.10.011_bib5","first-page":"171","article-title":"Rates of serious infectious events and opportunistic infections in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis treated with etanercept or placebo in clinical trials","volume":"66","author":"Hamza","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2007.10.011_bib6","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.06.012","article-title":"Herpes zoster in immunocompromised patients: incidence, timing, and risk factors","volume":"118","author":"Wung","year":"2005","journal-title":"Am J Med"},{"issue":"Suppl. II","key":"10.1016\/j.jbspin.2007.10.011_bib7","first-page":"118","article-title":"Reactivation of herpesvirus (HHV-1 and HHV-3) infections is increased in RA patients treated with adalimumab or infliximab","volume":"66","author":"Strangfeld","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2007.10.011_bib8","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1348-0421.2000.tb02599.x","article-title":"IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella\u2013zoster virus at an early stage of varicella","volume":"44","author":"Torigo","year":"2000","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jbspin.2007.10.011_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0002-9343(91)90568-I","article-title":"Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate","volume":"90","author":"Antonelli","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2007.10.011_bib10","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/kel328","article-title":"Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders","volume":"45","author":"Wolfe","year":"2006","journal-title":"Rheumatology (Oxford)"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X08001413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X08001413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T14:56:20Z","timestamp":1545836180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X08001413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1297319X08001413"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2007.10.011","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}